BioPorto

BioPorto is a company listed under the stock ticker BIOPOR (DK).

View the org chart displaying its 12 main executives

Most searched biographies at BioPorto

• Peter Mørch Eriksen, Chief Executive Officer
• Don Hardison, Vice Chairman of the Board
• John McDonough, Chairman of the Board

Popular executive movements at BioPorto

• Gry Louise Husby, who was Group General Counsel, is promoted to Chief Legal Officer and Executive Vice President  (posted on April 12 2024).
• Peter Mørch Eriksen, who was Interim Chief Executive Officer, is promoted to Chief Executive Officer  (posted on April 3 2024).
• Anthony Pare, Chief Executive Officer, has left the company  (posted on January 10 2024).

Click here to view some more movements at BioPorto

Create your alert
to follow the executive moves at BioPorto.

BioPorto has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by BioPorto

• BioPorto Receives FDA 510(k) Clearance for NGAL Test in the United States First Test to Aid in Assessing AKI Risk for Patients Aged 3 Months Through 21 Years
• BioPorto Provides a Business Update
• News - Bioporto

Social media about BioPorto

• BioPorto on Wikipedia, Google News & Yahoo Finance
• BioPorto on LinkedIn, Twitter & YouTube

Contact by email its executives including Nis Kruse

Call BioPorto at +45 ...

View the org chart

Register to receive your alert

Report an error